Answers are grounded in this paper and cite their sources.
Rhabdomyosarcoma is a group of soft-tissue sarcomas that share features of skeletal myogenesis, but show extensive heterogeneity in histology, age and site of onset, and prognosis. This review matches recent molecular data with biological features of rhabdomyosarcoma. Alterations in molecular pathways, animal models, cell of origin and potential new therapeutic targets are discussed.
No takes yet. Share an insight, caveat, or question.
Giovanni et al. (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: